Cargando…
Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
Current therapy for human immunodeficiency virus (HIV-1) infection relies primarily on the administration of anti-retroviral nucleoside analogues, either alone or in combination with HIV-protease inhibitors. Although these drugs have a clinical benefit, continuous therapy with the drugs leads to dru...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852372/ https://www.ncbi.nlm.nih.gov/pubmed/20334651 http://dx.doi.org/10.1186/1742-6405-7-7 |